Skip to main content
Quidel secures FDA clearance, CLIA waiver for RSV assay on analyzer
6/29/2017

The FDA has given Quidel clearance for its Sofia RSV Fluorescent Immunoassay for use on the Sofia 2 Fluorescent Immunoassay Analyzer in rapid respiratory syncytial virus infection detection. The assay, which also received a CLIA waiver, is indicated to be used in nasopharyngeal aspirate/wash and nasopharyngeal swab specimens from symptomatic pediatric patients.

Full Story: